HIGH CONTENT SCREENING MARKET ANALYSIS

High Content Screening Market, By Product Type (Cell Imaging and Analysis Equipment, Consumables, HCS Software, HCS Services), By Application (Primary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling, Others), By End User (Pharmaceutical Organizations, Biotechnology Organizations, Research Institutes, Independent CRO, Government Organizations, Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2030

Published In : Jun 2023
Code : CMI3487
Pages :167
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Market News

Global High Content Screening Market: Key Developmets

In November 2022, , a company that develops and produces particle engineering platforms, announced the release of the Automated Library Synthesis (ALiS) System. This platform promotes medication synthesis automation as well as high-throughput assessment of lipid nanoparticle (LNP) formulations and mRNA candidates

In December 2022, PhoreMost-a new-model drug discovery company based in Cambridge, U.K. and -a Japan-based company specialized in discovery of novel high-value therapeutic cells and therapeutic cells, have formed a strategic research agreement to advance current phenotypic drug screening through the use of artificial intelligence (AI)